Acorn Capital Advisors, LLC Portfolio Holdings

Acorn Capital Advisors, LLC

  • $197 Billion
  • Q3 2025

Acorn Capital Advisors, LLC has filed its 13F form on November 14, 2025 for Q3 2025 where it was disclosed a total value porftolio of $197 Billion distributed in 20 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Cg Oncology Inc with a value of $45.6B, Uro Gen Pharma Ltd. with a value of $25.1B, Puma Biotechnology, Inc. with a value of $21.9B, Trevi Therapeutics, Inc. with a value of $19.6B, and Terns Pharmaceuticals, Inc. with a value of $14.8B.

Examining the 13F form we can see an increase of $44.1B in the current position value, from $153B to 197B.

Acorn Capital Advisors, LLC is based out at New York, NY

Below you can find more details about Acorn Capital Advisors, LLC portfolio as well as his latest detailed transactions.

Portfolio value $197 Billion
Healthcare: $116 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
Cg Oncology Inc
-
$45.6 Billion 23.14% of portfolio
-
Q4 2024 New
$553M
$25.1 Billion 12.76% of portfolio
1,259,749
Q2 2025 Reduced 16.92%
$226M
$21.9 Billion 11.14% of portfolio
4,131,299
Q2 2025 Added 4.85%
$661M
$19.6 Billion 9.96% of portfolio
2,144,844
Q1 2025 Added 7.19%
$846M
$14.8 Billion 7.52% of portfolio
1,971,264
Q4 2024 New
$133M
$13.2 Billion 6.68% of portfolio
2,580,517
Q2 2025 Added 19.9%
Bicara Therapeutics
-
$10.2 Billion 5.16% of portfolio
-
Q1 2025 Added 0.0%
Onkure Therapeutics Inc
-
$7.81 Billion 3.96% of portfolio
-
Q2 2025 Added 97.24%
$62.1M
$7.62 Billion 3.87% of portfolio
1,752,115
Q2 2025 Added 36.91%
Verastem Inc
-
$6.88 Billion 3.49% of portfolio
-
Q4 2024 Added 72.41%
Cybin Inc
-
$4.31 Billion 2.19% of portfolio
-
Q1 2025 Added 0.0%
$93.2M
$4.04 Billion 2.05% of portfolio
1,962,084
Q3 2025 Added 39.28%
$162M
$3.68 Billion 1.87% of portfolio
595,744
Q2 2025 Added 0.89%
$32.3M
$3.34 Billion 1.69% of portfolio
4,835,111
Q2 2025 Added 19.92%
Jasper Therapeutics
-
$3.29 Billion 1.67% of portfolio
-
Q3 2025 New
$35.9M
$2.16 Billion 1.1% of portfolio
1,139,363
Q1 2025 Reduced 0.67%
$251M
$935 Million 0.47% of portfolio
273,349
Q3 2025 Added 77.81%
-
$733 Million 0.37% of portfolio
-
Q4 2024 New
Vyne Therapeutics Inc
-
$199 Million 0.1% of portfolio
-
Q3 2025 Reduced 20.36%

Summary

  • Portfolio
  • No. of Stocks 20
  • Current Value $197 Billion
  • Prior Value $153 Billion
  • Filing
  • Period Q3 2025
  • Filing Date November 14, 2025
  • Form Type 13F-HR
  • Activity in Q3 2025
  • New Purchases 1 stocks
  • Additional Purchases 2 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 1 stocks
Track This Portfolio

Track Acorn Capital Advisors, LLC Portfolio

Follow Acorn Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acorn Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acorn Capital Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email